Research Centre | Company Search | Charting | Stock Screener | Performance Tables | Financial Diary | Investing Board
GlaxoSmithKline (GSK)
Share Price: 1,555.60p Change Today: -20.40p  Market Cap: £77,156m

GlaxoSmithKline Overview

UK-based GlaxoSmithKline is one of the world's leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

GlaxoSmithKline Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-13 26,505.00 6,647.00 108.40p 14.9 n/a -3% 78.00p 4.8%
31-Dec-14 23,006.00 2,968.00 95.40p 14.4 n/a -12% 80.00p 5.8%
31-Dec-15 23,923.00 10,526.00 75.70p 18.1 n/a -21% 80.00p 5.8%
31-Dec-16 27,889.00 1,939.00 102.40p 15.3 0.4 +35% 80.00p 5.1%
31-Dec-17 30,186.00 3,525.00 111.80p 11.8 1.3 +9% 80.00p 6.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

GlaxoSmithKline Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-18 29,942.15 7,447.37 108.10p 14.6 n/a -3% 80.00p 5.1%
31-Dec-19 30,636.37 7,586.61 112.67p 14.0 3.3 +4% 80.13p 5.1%

Copyright © 2018 FactSet Research Systems Inc. All rights reserved.

GlaxoSmithKline Company Announcements

Director/PDMR Shareholding 16-Jul-2018 14:51 RNS
Director/PDMR Shareholding 16-Jul-2018 11:11 RNS
Director/PDMR Shareholding 13-Jul-2018 16:16 RNS

Latest GlaxoSmithKline Director Deals

Traded Action Notifier PriceAmountValue
13-Jul-18 Buy Dividends David Redfern 1,586.50p 23 £364.89
13-Jul-18 Buy Dividends Victoria Whyte 1,586.50p 19 £301.43
12-Jul-18 Buy Dividends David Redfern 1,570.91p 1,838 £28,873.33

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Price Data

Currency UK Pounds
Share Price 1,555.60p
Change Today -20.40p
% Change -1.29 %
Volume 3,519,631
13-Jul-18 Close 1,576.00p
Shares Issued 4,959.87m
Market Cap £77,156m
Year End 31-Dec-17

What The Brokers Say

Strong Buy 12
Buy 2
Neutral 12
Sell 0
Strong Sell 1
Total 27
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GlaxoSmithKline Dividends

  Latest Previous
  Q1 Q4
Ex-Div 10-May-18 22-Feb-18
Paid 12-Jul-18 12-Apr-18
Amount 19.00p 23.00p

Trades for 16-Jul-2018

Time Volume / Share Price
15:13 242 @ 1,555.60p
15:13 39 @ 1,555.60p
15:13 561 @ 1,555.60p
15:13 208 @ 1,555.60p
15:13 353 @ 1,555.60p

GlaxoSmithKline Key Personnel

CFO Simon Dingemans
CEO Emma Walmsley



www.bolsamania.com www.sharecast.com http://www.proshareclubs.co.uk/www.digitallook.com